| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 07/26/2011 | CA2784919A1 Compositions and methods relating to argininosuccinate synthetase |
| 07/26/2011 | CA2633354C Methods of using a g protein-coupled receptor to identify peptide yy (pyy) secretagogues and compounds useful in the treatment of conditions modulated by pyy |
| 07/26/2011 | CA2630341C Process for producing isoprenoid compounds by microorganisms |
| 07/26/2011 | CA2569767C Plastid transit peptides |
| 07/26/2011 | CA2474853C Methods, devices, and systems using acoustic ejection for depositing fluid droplets on a sample surface for analysis |
| 07/26/2011 | CA2453528C Novel fusion proteins and assays for molecular binding |
| 07/26/2011 | CA2448975C Sequences for detection and identification of methicillin-resistant staphyloccocus aureus |
| 07/26/2011 | CA2439679C Method for assaying non-spermine/spermidine activity of spermidine/spermine n1-acetyltransferase (ssat) |
| 07/26/2011 | CA2431170C Method of analyzing expression of gene |
| 07/26/2011 | CA2411249C Gasc1 gene |
| 07/26/2011 | CA2389220C Methods for profiling and classifying tissue using a database that includes indices representative of a tissue population |
| 07/26/2011 | CA2376346C Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin, and comprising at least one intron sequence |
| 07/26/2011 | CA2352467C Apoptosis-inducing factor |
| 07/26/2011 | CA2332510C In situ hybridization method for detecting target nucleic acid |
| 07/26/2011 | CA2295859C Cytokinin oxidase |
| 07/26/2011 | CA2221409C Mch2, an apoptotic cysteine protease, and compositions for making and methods of using the same |
| 07/26/2011 | CA2215350C Transforming growth factor alpha hii |
| 07/22/2011 | CA2728965A1 Optical imaging for identifying cells labeled with fluorescent nanoparticles |
| 07/21/2011 | WO2011088451A1 Uses of influenza virus-like particles (vlps) for characterization of neuraminidase and hemagglutinin activity |
| 07/21/2011 | WO2011088391A2 Predicting and reducing alloimmunogenicity of protein therapeutics |
| 07/21/2011 | WO2011088380A1 Methods of using fut2 genetic variants to diagnose crohn's disease |
| 07/21/2011 | WO2011088306A1 Methods of using genetic variants to diagnose crohn's disease |
| 07/21/2011 | WO2011088237A1 Methods of using znf365 genetic variants to diagnose crohn's disease |
| 07/21/2011 | WO2011088226A2 Detection of gastrointestinal disorders |
| 07/21/2011 | WO2011088193A2 Fluorophore chelated lanthanide luminiscent probes with improved quantum efficiency |
| 07/21/2011 | WO2011088125A1 Mutations in the lnk gene in patients with myeloproliferative neoplasms and other hematolymphoid malignancies |
| 07/21/2011 | WO2011087946A1 Screening assay employing dex and gdf8 |
| 07/21/2011 | WO2011087928A1 Oligonucleotides and methods for detecting kras and pik3ca mutations |
| 07/21/2011 | WO2011087855A1 Method for evaluating inhibitory polynucleotide efficiency and efficacy |
| 07/21/2011 | WO2011087803A1 Assay for monitoring parathyroid hormone (pth) variants by tandem mass spectrometry |
| 07/21/2011 | WO2011087711A1 Methods of detecting microorganisms and kits therefore |
| 07/21/2011 | WO2011087709A2 Eml4-alk translocations in lung cancer |
| 07/21/2011 | WO2011087707A1 Hypertheromostable endonuclease iv substrate probe |
| 07/21/2011 | WO2011087456A1 Sequence-selective recognition of nucleic acids using nanoparticle probes |
| 07/21/2011 | WO2011087366A1 Means and methods for distinguishing fecv and fipv |
| 07/21/2011 | WO2011087178A1 Screening method for the in-vivo active indicator of human mesenchymal stem cells |
| 07/21/2011 | WO2011087009A1 Regulatory gene controlling saccharometabolism, lipid metabolism, obesity and life, protein, and screening method |
| 07/21/2011 | WO2011086840A1 Photo-sensitive gene expression regulation system |
| 07/21/2011 | WO2011086189A2 Constructs, vectors and cyanobacteria for the synthesis of fatty alcohols, and methods for producing fatty alcohols in cyanobacteria |
| 07/21/2011 | WO2011086179A1 Methods for diagnosis and treatment of cutaneous t cell lymphomas |
| 07/21/2011 | WO2011086174A2 Diagnostic gene expression platform |
| 07/21/2011 | WO2011086161A2 Biomarkers of ageing |
| 07/21/2011 | WO2011086118A1 In vivo determination of the lokalization of dna double-stand breaks and application thereof |
| 07/21/2011 | WO2011086116A1 Method for identifying an inhibitors of protein translocation |
| 07/21/2011 | WO2011086006A1 Method for detecting more than one target in a pcr-based approach applying an unspecific dye which is not interfering with the emission of fluorophore-labeled probes |
| 07/21/2011 | WO2011085653A1 Method and kit for identifying and treating graves' disease |
| 07/21/2011 | WO2011085491A1 Multiplex amplification for the detection of nucleic acid variations |
| 07/21/2011 | WO2011066008A3 Blood transcriptional signature of active versus latent mycobacterium tuberculosis infection |
| 07/21/2011 | WO2011064740A3 Product and preparation process of a substrate for a rapid detection of helicobacter pylori |
| 07/21/2011 | WO2011057003A3 Methods of using small rna from bodily fluids for diagnosis and monitoring of neurodegenerative diseases |
| 07/21/2011 | WO2011054893A3 Biomarkers predictive of progression of fibrosis |
| 07/21/2011 | WO2011034906A3 Recurrent gene fusions in prostate cancer |
| 07/21/2011 | WO2011032054A3 Analysis of y-chromosome str markers |
| 07/21/2011 | WO2011031895A3 Systems and methods for identifying microparticles |
| 07/21/2011 | WO2011029007A3 Human lymphoid tissue inducer (lti) cell compositions and methods of use |
| 07/21/2011 | WO2011022589A3 Detection of enterovirus |
| 07/21/2011 | WO2011008947A3 Treatment and diagnosis of immune disorders |
| 07/21/2011 | WO2011000998A3 Method for the replication, amplification or sequencing of a dna template |
| 07/21/2011 | WO2010151566A8 Compositions and methods for detecting nucleic acid from mollicutes |
| 07/21/2011 | WO2010148039A3 Methods and compositions for long fragment read sequencing |
| 07/21/2011 | WO2010135705A3 Biological bar code |
| 07/21/2011 | WO2010096388A4 Quenched dendrimeric dyes for florescence detection |
| 07/21/2011 | WO2008094902A3 Compositions and methods for the detection of a nucleic acid using a cleavage reaction |
| 07/21/2011 | WO2008089270A3 Flow chamber device for neutralization of cancer cells |
| 07/21/2011 | US20110179515 Tomato hybrid ps01059664 |
| 07/21/2011 | US20110179514 Tomato hybrid ps02326502 |
| 07/21/2011 | US20110179513 Tomato hybrid ps02431185 and parent lines thereof |
| 07/21/2011 | US20110179512 Tomato hybrid ps02420487 and parent lines thereof |
| 07/21/2011 | US20110179507 Laglidadg homing endonuclease variants having mutations in two functional subdomains and use thereof |
| 07/21/2011 | US20110179504 Method For Coral Tissue Cultivation And Propagation |
| 07/21/2011 | US20110179502 Modulation of gm98 (mrf) in remyelination |
| 07/21/2011 | US20110179501 Methods for Reverting Methylation by Targeting DNMT3A and DNMT3B |
| 07/21/2011 | US20110178402 ULTRASONIC MEASUREMENT OF pH IN FLUIDS |
| 07/21/2011 | US20110178272 Isolated bitter taste receptor polypeptides |
| 07/21/2011 | US20110178182 Enriched nanostructure composition |
| 07/21/2011 | US20110178163 Mir-182 in the diagnosis and treatment of cancer |
| 07/21/2011 | US20110178161 Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin |
| 07/21/2011 | US20110178159 Inhibitory rnas that regulate hematopoietic cells |
| 07/21/2011 | US20110178156 Method of suppressing pRb deficiency-induced tumor formation |
| 07/21/2011 | US20110178154 gene expression profile that predicts ovarian cancer subject response to chemotherapy |
| 07/21/2011 | US20110178153 Methods of treating chemoresistance and relapse in cancer cells |
| 07/21/2011 | US20110178138 Inhibitors of protein prenyltransferases |
| 07/21/2011 | US20110178110 Genotype and Expression Analysis for Use in Predicting Outcome and Therapy Selection |
| 07/21/2011 | US20110178106 5-quinolinone and imidazopyridine compounds and use thereof |
| 07/21/2011 | US20110178102 Sir2 regulation |
| 07/21/2011 | US20110178004 Hepatitis b virus pre-s1 derived synthetic polypeptides and uses thereof |
| 07/21/2011 | US20110178003 Optimized dengue virus entry inhibitory peptide (10an) |
| 07/21/2011 | US20110177996 Regulatory proteins in lung repair and treatment of lung disease |
| 07/21/2011 | US20110177975 Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays |
| 07/21/2011 | US20110177974 Neural proteins as biomarkers for nervous system injury and other neural disorders |
| 07/21/2011 | US20110177972 Compositions and methods for the treatment of immune related diseases |
| 07/21/2011 | US20110177971 Method for diagnosing the stage of a thyroid tumor |
| 07/21/2011 | US20110177970 Methods for predicting or monitoring whether a patient affected by a cancer is responsive to a treatment with a molecule of the taxoid family |
| 07/21/2011 | US20110177969 The role of il17rd and the il23-1l17 pathway in crohn's disease |
| 07/21/2011 | US20110177967 Methods and compositions using splicing regulatory proteins involved in tumor suppression |
| 07/21/2011 | US20110177965 Compositions and methods for prognosis of gastric cancer |
| 07/21/2011 | US20110177963 Variation in the CHI3L1 Gene Influences Serum YKL-40 Levels, Asthma Risk and Lung Function |
| 07/21/2011 | US20110177958 Methods and materials for identifying polymorphic variants, diagnosing susceptibilities, and treating disease |
| 07/21/2011 | US20110177957 Polymorphisms Associated With Age-Related Macular Degeneration And Methods For Evaluating Patient Risk |
| 07/21/2011 | US20110177605 On-Board Control for Analytical Elements |